Skip to main content
Clinical Trials/NL-OMON25137
NL-OMON25137
Completed
Not Applicable

Tailored lymphadenectomy using Sentinel node Navigation surgery in submucosal esophageal Adenocarcinoma Patients: SNAP-III study

niversity Medical Center Utrecht0 sites10 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
<p>High-risk T1b esophageal adenocarcinoma</p>
Sponsor
niversity Medical Center Utrecht
Enrollment
10
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\)High\-risk submucosal EAC on histology (diagnosed in ER specimen) confirmed by an expert gastrointestinal pathologist, defined as:
  • a) Infiltration of EAC into the deep submucosa (\>500 µm), and/or;
  • b) Poor differentiation (G3\) or undifferentiated (G4\) EAC, and/or;
  • c) Presence of lymphovascular invasion
  • 2\)Tumor\-free deep vertical resection margins in the ER specimen
  • 3\)Clinically staged as T1N0M0
  • 4\)Fit for endoscopy and surgery per institution’s standards
  • 5\)Older than 18 years of age at time of informed consent
  • 6\)Willing and able to comply with follow\-up requirements
  • 7\)Written informed consent

Exclusion Criteria

  • 1\)History of esophageal squamous cell carcinoma
  • 2\)Clinically staged as N\+
  • 3\)Prior neoadjuvant chemoradiation therapy
  • 4\)Prior esophageal surgery interfering with the procedure
  • 5\)Other primary tumor with a life\-expectancy less than 3 years
  • 6\)Known allergy for the radioactive tracer (technetium) or dye (indocyanine green)
  • 7\)Severe medical comorbidities precluding endoscopy and/or surgery
  • 8\)Pregnant or planning to become pregnant during period of study
  • 9\)Refusing or unable to provide written informed consent
  • 10\)Participation in another study within the 30 days preceding or during the present study, interfering with participation in the current study

Outcomes

Primary Outcomes

Not specified

Similar Trials